Ying Ma

Ying Ma

Auto-generated profile, based on publicly available information

Ying Ma

Key Laboratory of Medical Electrophysiology of Ministry of Education and Medical Electrophysiological Key Lab of Sichuan Province, Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, 646000 Sichuan, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YMYing Ma
Ying Ma
YLyuan li
yuan li
YYYan Yang
Yan Yang
PLpengyun li
pengyun li
Vascular repair upon injury is a frequently encountered pathology in cardiovascular diseases, which is crucial for the maintenance of arterial homeostasis and function. Stem/progenitor cells located on vascular walls have multidirectional differentiation potential and regenerative ability. It has been demonstrated that stem/progenitor cells play an essential role in the basic medical research and disease treatment. The dynamic microenvironment around the vascular wall stem/progenitor cells (VW‐S/PCs) possesses many stem cell niche‐like characteristics to support and regulate cells’ activities, maintaining the properties of stem cells. Under physiological conditions, vascular homeostasis is a cautiously balanced and efficient interaction between stem cells and the microenvironment. These interactions contribute to the vascular repair and remodeling upon vessel injury. However, the signaling mechanisms involved in the regulation of microenvironment on stem cells remain to be further elucidated. Understanding the functional characteristics and potential mechanisms of VW‐S/PCs is of great significance for both basic and translational research. This review underscores the microenvironment‐derived signals that regulate VW‐S/PCs and aims at providing new targets for the treatment of related cardiovascular diseases.